Inhibiting 31 beta HSD1 to eliminate the oncogenic effects of progesterone in prostate cancer

Hou, ZM; Huang, SS; Mei, ZJ; Chen, LL; Guo, JC; Gao, YY; Zhuang, Q; Zhang, XB; Tan, QL; Yang, T; Liu, Y; Chi, YN; Qi, LFR; Jiang, T; Shao, XF; Wu, Y; Xu, XJ; Qin, J; Ren, RB; Tang, HR; Wu, DL; Li, ZF

Li, ZF (通讯作者),Chinese Acad Sci, Univ Chinese Acad Sci, CAS Ctr Excellence Mol Cell Sci, Shanghai Inst Biochem & Cell Biol,State Key Lab C, 320 Yueyang Rd, Shanghai 200031, Peoples R China.;Wu, DL; Li, ZF (通讯作者),Tongji Univ, Tongji Hosp, Sch Med, Dept Urol, Shanghai 200065, Peoples R China.;Tang, HR (通讯作者),Fudan Univ, Zhongshan Hosp, Metabon & Syst Biol Lab,Shanghai Int Ctr Mol Phen, Sch Life Sci,State Key Lab Genet Engn,Human Pheno, Shanghai 200438, Peoples R China.

CELL REPORTS MEDICINE, 2022; 3 (3):

Abstract

Prostate cancer continuously progresses following deprivation of circulating androgens originating from the testis and adrenal glands, indicating the ......

Full Text Link